The GLP-1 Blockbuster Maker Widens Its Lead as the Diversified Healthcare Giant Posts Steady Growth
Quick Read Lilly posted 53.9% revenue growth and 480% net income growth driven by GLP-1 drugs Mounjaro and Zepbound. Lilly’s operating margin hit 48.3% versus J&J’s 30.2%. Gross margin reached 82.9%. Novo Nordisk’s oral Wegovy approval in December 2025 introduces new competition to Lilly’s injectable GLP-1 franchise. It sounds nuts, but SoFi is giving new active […]
People Who Go Off GLP-1s Are Experiencing a Sudden and Terrible Hunger
Glucagon-like peptide-1 (GLP-1) receptor agonist drugs, like the popular weight-loss jabs Wegovy and Ozempic, have proven to be immensely effective. Beyond allowing patients to significantly reduce their weight, they’ve been shown to have a constellation of other health benefits, like lowering the risk of heart disease and staving off diabetic kidney disease, Parkinson’s, and Alzheimer’s. […]
Medicina, Vol. 62, Pages 143: GLP-1 Receptor Agonist Exenatide Protects Against Doxorubicin-Induced Cardiotoxicity Through the SIRT1 Pathway: An Electrocardiographic, 99mTc-PYP Scintigraphic, and Biochemical Study
Medicina, Vol. 62, Pages 143: GLP-1 Receptor Agonist Exenatide Protects Against Doxorubicin-Induced Cardiotoxicity Through the SIRT1 Pathway: An Electrocardiographic, 99mTc-PYP Scintigraphic, and Biochemical Study Medicina doi: 10.3390/medicina62010143 Authors: Musa Salmanoglu Gulcin Ercan Hanife Seyda Genç Serdar Savaş Gül Hatice Aygün Background and Objectives: This study was designed to evaluate the potential cardioprotective effect of Exenatide […]
Gut-derived GLP-1 released by rare sugar D-allulose cooperates with insulin to activate left-sided vagal afferents and enhance insulin sensitivity
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) ameliorate hyperglycemia by directly stimulating insulin secretion from the pancreas. In contrast, the physiological role of short-lived endogenous GLP-1 remains unclear, largely because of its limited access to pancreatic {beta} cells. Here, we show that D-allulose-induced intestinal GLP-1 secretion (AIGS) cooperates with insulin to reduce blood glucose levels by enhancing […]
Doctors urge caution as study finds rapid weight regain after weight-loss drugs
A study found people who stopped GLP-1 weight-loss drugs such as Ozempic, regained weight rapidly and faced higher risks of diabetes, high cholesterol and high blood pressure. #weightloss #health For more info, please go to https://globalnews.ca Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc Follow Global News on X HERE: http://bit.ly/1Toz8mt Follow Global News on TikTok […]
Wegovy just became available in an unexpected place
Days after hitting the market, the new pill version of Novo Nordisk’s wildly popular weight-loss drug will be available through Amazon’s online pharmacy. Amazon joins telehealth providers, discount prescription stalwart GoodRx, and even Novo Nordisk itself in providing the novel weight-management drug for consumers who want to pay out of pocket. With the introduction of […]
Amazon Pharmacy Disrupts Weight Loss Market with Oral Wegovy: $149 Cash-Pay Option and Same-Day Delivery
What You Should Know – Amazon Pharmacy has officially added Novo Nordisk’s Wegovy® pill—the first and only FDA-approved oral GLP-1 for weight management—to its nationwide delivery platform. – To lower barriers to care, Amazon is offering a transparent cash-pay option starting at $149 per month for those without insurance, while eligible commercially insured customers may […]
I’m a Dietitian Taking A GLP-1. These Are My Go-To Simple Meals
These medications changed not only my appetite, but the entire way I think about food, hunger, and self-care.
Study reveals how fast weight returns after ending GLP-1 drugs
Post Content
Novo Nordisk Gets Discounted as Investors Look Past the Next Phase of GLP-1 Growth
